BRAIN Biotech AG (ETR:BNN)

BRAIN Biotech AG Revenue

BRAIN Biotech AG had revenue of 11.33M EUR in the quarter ending June 30, 2026, a decrease of -16.50%. This brings the company's total for the last twelve months to 46.08M, down -14.06% year-over-year. In the fiscal year ending September 30, 2025, BRAIN Biotech AG had annual revenue of 50.22M, down -9.52%. That makes BRAIN Biotech AG the 27,740th largest company in the world by revenue and 427th in Germany.

• Revenue (ttm): 46.08M
• Revenue Growth: -14.06%
• P/S Ratio: 1.24
• Revenue / Employee: 164.56K
• Employees: 280
• Market Cap: 57.24M

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Brainbiocatalysts 45.80M 91.2%
• BRAINBioincubator 4.41M 8.8%

By Geography

Chart

• Other Abroad 16.48M 33.2%
• USA 12.30M 24.8%
• Netherlands 8.85M 17.8%
• Germany 5.52M 11.1%
• United Kingdom 4.30M 8.7%
• France 2.18M 4.4%

Fiscal year ended Sep 30, 2025 See the full BRAIN Biotech AG breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2025	50.22M	-5.28M	-9.52%
Sep 30, 2024	55.50M	-725.00K	-1.29%
Sep 30, 2023	56.23M	5.93M	11.79%
Sep 30, 2022	50.30M	11.07M	28.23%
Sep 30, 2021	39.22M	158.00K	0.40%

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 2, 2026

Data Sources Report a data error